The European School of Multimodality Imaging & Therapy (ESMIT)

Fundamentals of Research in Imaging and Theranostics Part 2
2025-03-01 08:00 - 2027-03-30 17:00 (Europe/Vienna)
UEMS EACCME has granted the accreditation of 4.5 CME credits for this event.

This online course is part of a longer line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

For phase I/II clinical studies with radiopharmaceuticals to understand:

The principles of technical realisation of the study including assessment of safety of investigational medicinal product

The statistical considerations, including the estimation of number of subjects to be enrolled

The regulatory requirements for performing clinical studies with radiopharmaceutical with special focus on diagnostic radiopharmaceuticals and to summarise the particularities of these studies

The ethical and medical considerations in common and vulnerable populations

The principles of preparing the clinical study protocol

The objectives, endpoints and outcome measures

The principles of patient selection, inclusion and non-inclusion criteria

The principles of establishment of the standard of truth, the role of the comparator, superiority/non-inferiority/equivalence(?) studies) & practical examples

Target Audience

Personnel involved in designing and/or performing phase I/II clinical research with diagnostic radiopharmaceuticals (e.g. nuclear medicine physicians, pharmacists, physicists, nurses, technologist, administrative staff).

Personnel involved in assessment of the ethical, medical and methodologic aspects of phase I/II research protocols with diagnostic radiopharmaceuticals.

All professionals interested in phase I/II clinical research with diagnostic radiopharmaceuticals

Faculty

Chiara GranaSpeaker

Bart de KeizerSpeaker

Caroline StokkeSpeaker

Jean-Noel TalbotSpeaker

Luisa Roldao PereiraSpeaker

John Andrei IagaruSpeaker

Sona BalogovaSpeaker

Bringing Alpha Therapies into Clinical Practice
2025-10-30 08:00 - 2027-11-30 17:00 | Online
UEMS EACCME has granted the accreditation of 3 CME credits for this event.

This online course offers a comprehensive introduction to alpha therapy in nuclear medicine, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting radioisotopes to deliver lethal doses of radiation directly to cancer cells while sparing healthy tissues. It is highly efficient and lately increasingly explored for scientific purposes in the oncologic domain . With this course we aim at bringing Alpha Therapies into clinical practice through various, relevant presentations. A panel of experts and EANM members will update you on the type of alpha-emitting radioisotopes available, describing all important steps required for production and radiopharmaceutical development. The advantages, but also the challenges related to the use of Alpha therapy will amply be discussed and supported by clinical examples. You will be initiated in the existing and ongoing therapeutic trials, with the best yet to come. Dosimetry will play a pivotal role in this course, underlying its role in clinical practice. Finally, The Alphamet project will be presented, allowing you to get updated with the latest insights from Theranostics.

RPH

Targeted Alpha Therapy (TAT) represents a cutting-edge advancement in cancer treatment, harnessing the potent, cell-killing power of alpha particles to precisely destroy malignant cells while minimizing damage to surrounding healthy tissue. This part of the course course explores the transformative potential of TAT, highlighting its exceptional potency, unique ability to overcome radio-resistance, and its role in modern theranostics. You’ll gain insight into the selection of optimal alpha-emitting radionuclides, the biological advantages of short-range high-energy emissions, and the complex challenges involved in the development, production, and clinical translation of these innovative therapies. Join us to deepen your knowledge and be part of the future of targeted radiopharmaceuticals in oncology.

Oncology

In this part of the course, participants will explore the main advantages of alpha-emitting radionuclides in oncology, while also gaining an understanding of the clinical challenges associated with their use. You will become familiar with the key clinical aspects of Alpha-Therapy, supported by real-world perspectives and case insights. The course also highlights current and upcoming therapeutic trials, providing valuable knowledge on the future direction of this rapidly evolving field.

Dosimetry

Participants will begin by exploring the basic concepts of dosimetry with alpha emitters, highlighting key differences from beta emitter dosimetry. The course then delves into the clinical relevance of alpha dosimetry, demonstrating how accurate dose assessments can inform and optimize the management of patients undergoing treatment with alpha radiotherapeutics. In addition, the course presents the Alphamet project, a major European initiative that addresses the specific metrological challenges associated with targeted alpha therapies. By examining the goals and contributions of Alphamet, learners will gain insight into how this research supports the safe and effective integration of alpha therapy into routine clinical practice.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

To gain an overview of the main advantages of Alpha-radionuclides

To learn about the challenges of alpha emitters, complex production; transport issues, waste management and handling

To get insights on radiobiology: radiotoxicity & effectiveness

To have a comprehensive review of research candidates

To provide an overview of the main advantages when using Alpha-Therapy in clinical practice

To learn about the clinical challenges when using Alpha-Therapy

To get insights into current and future trials focusing on Alpha-Therapy

To learn the most basic aspects about dosimetry of alpha emitters showing the main differences with dosimetry of beta emitters

To learn how dosimetry results could be used in the management of patients treated with radiopharmaceuticals that include alpha emitters

To learn on the Alphamet project, which addresses the unique and unmet metrological challenges of targeted alpha therapies, contributing to their safe and optimised implementation into routine clinical practice

Target Audience

Nuclear medicine physicians, radiologists, medical oncologists, urologists, radiation oncologists, medical physicists, biologists, researchers

Radiochemists, radiopharmacists, physicists, medical physicists, biologists

ProgrammeClick to see the full event programme. View the Programme

Faculty

Dana NiculaeSpeaker

Emma AnaheimSpeaker

Janke KleyhansSpeaker

Marianna TosatoSpeaker

Wolfgang FendlerSpeaker

Mathias ZacherlSpeaker

Pablo Mínguez GabiñaSpeaker

Mike SathekgeSpeaker

Daniela Oprea-LagerSpeaker

Ana Denis-BacelarSpeaker

Joe O’SullivanSpeaker

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once enrolled, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

NucMed Essentials - MSK Basics
2025-11-03 00:00 - 2027-11-30 23:59
UEMS EACCME has granted the accreditation of 5 CME credits for this event.

New ESMIT Learning format: Self-paced online course followed by a live session with the course faculty, where participants are able to ask their questions live!*

Nuclear Medicine Essentials: The Basics of MSK provides a comprehensive introduction to musculoskeletal applications in nuclear medicine, focusing on both diagnostic and therapeutic techniques. Participants will explore the fundamental principles of bone scintigraphy, including its physiological basis, imaging protocols, and wide range of clinical applications, with emphasis on its continued importance in patient care. The course also delves into advanced imaging through NaF PET, highlighting its uptake mechanisms, technical considerations, and growing role in oncology and other clinical contexts. Building on these diagnostic foundations, the course transitions into therapeutic strategies, such as the use of Radium-223 in the treatment of bone metastases, with attention to efficacy, safety, and radioprotection measures.

Beyond theoretical understanding, the program emphasizes practical application and clinical relevance. Learners will gain exposure to cutting-edge research, evidence-based workflows, and therapeutic innovations in the field. Radiosynovectomy for arthritis treatment is presented as an important example of nuclear medicine’s therapeutic scope, with procedural insights and expected outcomes supported by real-world case demonstrations. Departmental video presentations supplement each topic, offering participants a unique opportunity to see workflows and protocols in practice. By the end of the course, attendees will not only understand the fundamentals of musculoskeletal nuclear medicine but also appreciate its evolving role in modern imaging and therapy.

*The live follow-up session will only be held if there is interest – please submit your questions at the dedicated space on our eLearning platform. The date of the live session will be announced in due time.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

I. Understand the fundamentals of bone scan techniques:

Describe the theoretical considerations and acquisition protocols for bone scans.

Explain the clinical applications of bone scans across various pathologies.

II. Gain insights into NaF PET for bone imaging:

Summarize the theoretical considerations and acquisition protocols specific to NaF PET.

Recognize the essential applications of NaF PET in oncology and other clinical cases.

III. Explore therapeutic approaches for bone metastases using bone-seeking agents:

Review current theoretical knowledge and recent publications on the treatment of bone metastases.

Identify practical considerations and procedural steps involved in bone-seeking agent therapies.

IV. Learn the application of radiosynovectomy in managing arthritis:

Describe the indications, procedures, and expected outcomes of radiosynovectomy for arthritis treatment.

V. Apply knowledge through visual and practical insights from real-world clinical settings:

Assess clinical workflows and procedural nuances via department video presentations for each session.

Target Audience

Technologists, nuclear medicine physicians and residents

Faculty

Knut LiepeSpeaker

Jules Zhang-YinSpeaker

Paolo TurcoSpeaker

Personalized Medicine in Prostate Cancer: From Diagnostic to Therapy
2026-01-30 00:00 - 2028-01-30 23:59
This course has been accredited with 3 CME credits by the UEMS EACCME.

Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used in imaging and treatment of prostate cancer. PSMA-directed radionuclide therapy is an efficacious new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and beyond. The online course will cover the spectrum of radiolabelled PSMA tracers, techniques related to PSMA imaging, from diagnosis to therapy, with lectures, interactive case discussions, and relevant information for clinical practice.

Save yourself a seat!Enter the eLearning platform register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

PSMA PET-CT imaging- science and practice:

To provide an overview of clinical applications, normal biodistribution, variants, pitfalls and artefacts in PSMA PET-CT

To learn how to report PSMA PET-CT scans in primary staging and recurrence

Radionuclide PSMA therapy-science and practice (177Lu-PSMA therapies):

To gain knowledge on PSMA patients selection, management of common clinical challenges in implementing and delivering of radionuclide therapies, side effects and their management

To discuss current evidence and trends related to 177Lu-PSMA therapies

To learn about new or emerging targets and radioisotopes for Prostate cancer management

Target Audience

General nuclear medicine specialists, residents, radiologists, healthcare specialists who want to update their knowledge on molecular imaging and radionuclide therapy of prostate cancer including theranostics.

Faculty

Karolien GoffinSpeaker

Wolfgang FendlerSpeaker

EANM Focus Meeting 7: Molecular Imaging for a Personalised Treatment in Alzheimer's Disease
2026-02-27 00:00 - 2027-02-27 23:59
Alzheimer’s disease is a growing global health concern, now facing a pivotal moment with the approval of disease-specific treatments.

This Focus Meeting brought together international experts under the theme ‘An accurate diagnosis for an effective treatment with Molecular Imaging’ to explore the crucial role of imaging and biomarkers in improving diagnosis, treatment selection, and monitoring.

The goal was to reach a multidisciplinary consensus on the current state of the art and to make expert recommendations how to advance the field towards establishing clinical impact.

Register nowEnrol in the online course now for free! Register now

Faculty

Cecilia BoccaliniSpeaker

Paul BoonSpeaker

AngelaBradshawSpeaker

DiegoCecchinSpeaker

JavierArbizuSpeaker

FedericaAgostaSpeaker

MatthiasBrendelSpeaker

RikOssenkoppeleSpeaker

SebastianEngelborghsSpeaker

AlexanderDrzezgaSpeaker

NicolaiFranzmeierSpeaker

GiovanniFrisoniSpeaker

Valentina GaribottoSpeaker

TakeshiIwatsuboSpeaker

ShorenaJanelidzeSpeaker

FrankJessenSpeaker

RenaudLa JoieSpeaker

SilviaMorbelliSpeaker

VincentPlance Speaker

LucaRoccatagliataSpeaker

PedroRosa-NetoSpeaker

PhilipScheltensSpeaker

JoySniderSpeaker

CharlotteTeunissenSpeaker

NellekeTolboom Speaker

Elsmariekevan de GiessenSpeaker

Koen van LaereSpeaker

Andrea VarroneSpeaker

IgorYakushevSpeaker
